バイオイメージング市場レポート：動向、予測、競合分析 (2031年まで)

世界のバイオイメージング市場の将来は、クリニック、診断センター、病院、研究所の各市場における機会で有望視されています。世界のバイオイメージング市場は、2025年から2031年までのCAGRが15.7%で、2031年までに推定197億米ドルに達すると予測されています。この市場の主な促進要因は、イメージング技術の進歩に伴うバイオイメージング機器に対する需要の増加、慢性疾患の有病率の上昇と世界人口の高齢化、診断センターと放射性医薬品の増加です。

• Lucintelの予測によると、種類別ではX線撮影が、救急医療、整形外科、一般放射線科での採用が増加しているため、予測期間中に最も高い成長が見込まれます。
• 最終用途別では、病院が最大のセグメントであり続けると思われます。これは、病院が運営を合理化するためのインフラと高度な画像処理施設の開発が著しく進んでいるためです。
• 地域別では、確立された医療システム、洗練された医療施設、がんや心疾患の罹患率の増加、特に米国では医療保険制度の普及率が高いことから、予測期間中は北米が最大地域であり続けると思われます。

バイオイメージング市場の戦略的成長機会

バイオイメージング市場は、技術革新、より良い診断への需要、医療技術の進歩によって、新たな戦略的成長機会を見出しつつあります。これらの機会は、成長市場に参入しイノベーションを追求する利害関係者にとって極めて重要です。本セクションでは、バイオイメージング市場と医療の未来におけるアプリケーション別の5つの成長機会とその役割について概説します。

• 腫瘍イメージング：がんの罹患率が増加していることから、腫瘍イメージングがバイオイメージング市場の主要成長分野となっています。PET/CT、PET/MRI、分子イメージングなどの先進イメージング装置は、がんの正確な診断と治療計画に使用されています。腫瘍学イメージングにおけるAIの統合は、腫瘍同定の精度を向上させ、個別化された治療計画を可能にしています。この成長機会に先端画像ソリューション開発への投資が集まり、腫瘍学の観点から市場が拡大しています。
• 神経学イメージング：アルツハイマー病、パーキンソン病、多発性硬化症などの神経疾患の有病率が上昇していることから、神経学イメージングも主要な成長分野です。機能的MRI（fMRI）、拡散テンソル画像（DTI）、PETなどの新しい画像技術が、これらの疾患の診断と評価に使用されています。また、病変や悪性腫瘍の迅速なスクリーニングや検出に対する需要の高まりに対応するため、画像診断法も進化しています。この動向は、神経学を対象とする画像ソリューションの成長機会を生み出しています。
• 心臓病学イメージング：循環器画像診断市場は、心血管疾患の罹患率の増加と正確な診断の必要性により成長を続けています。3Dおよび4D心エコー、心臓MRI、CT血管造影などの高度な画像技術の使用により、手術をせずに心臓を評価する安全な方法が提供されています。AIベースのツールも心臓病画像診断システムに統合され、心臓疾患の診断を強化し、業務効率を向上させています。この市場成長は心臓画像技術の進歩に拍車をかけ、患者ケアを向上させています。
• 整形外科イメージング：整形外科イメージング市場は、人口の高齢化と筋骨格系疾患の有病率の上昇により拡大しています。整形外科の画像技術は診断に役立つだけでなく、治療計画やリハビリテーションの指針にもなっています。モバイル画像診断装置は、タイムリーな診断と治療介入が重要な整形外科診療において特に有用です。この動向は整形外科イメージング・ソリューションの需要を高め、高度なイメージング技術の開発を促進しています。
• 獣医イメージング：獣医用画像は、動物医療分野におけるより高度な診断ツールへの需要に後押しされ、バイオイメージング市場の成長に大きく貢献しています。超音波、MRI、CTなどの技術は、動物医療に非侵襲的なソリューションを提供する獣医診断にますます使用されるようになっています。さらに、動物医療用のAI主導型画像ソリューションの開発により、診断精度とワークフロー効率が向上しています。この成長機会がバイオイメージング市場拡大の新たな道を開いています。

バイオイメージング市場は、技術の進歩と正確で効果的な診断ツールに対する需要の高まりにより、大きな成長を遂げています。こうした動向は、腫瘍学、神経学、心臓病学、整形外科学、獣医学など、さまざまな分野で新たな成長機会を生み出しています。

バイオイメージング市場促進要因・課題

バイオイメージング市場は、技術進歩、経済状況、規制政策など、いくつかの市場促進要因・課題の影響を受けています。これらの要因は、市場の成長、イメージング技術の顧客受容、業界全体の構造を決定する上で重要な役割を果たしています。

促進要因：

• イメージングモダリティの技術向上：AI、ハイブリッドモダリティ、ワイヤレスイメージングシステムの統合など、イメージング技術の絶え間ない向上がバイオイメージング市場の成長を促進しています。これらの技術革新は診断精度とスピードを向上させ、市場拡大に寄与しています。
• 慢性疾患の発生率の上昇：がん、心血管疾患、神経疾患などの慢性疾患の有病率の増加が、高度な画像診断技術に対する需要を高めています。迅速かつ正確な診断の必要性が、最先端の画像技術の採用を促進しています。
• 標的医療への関心の高まり：個別化医療の動向の高まりは、3Dや4Dイメージングなどの高解像度を備えた高度なイメージング・システムに対する需要を促進しています。このような技術により、よりオーダーメイドの治療アプローチが可能になり、患者の予後改善につながります。
• 医療費の増加：各国政府および民間投資家による医療支出の増加は、先端画像技術の使用を促進しています。特に新興諸国における医療施設の整備は、画像ソリューションプロバイダーに新たな成長機会をもたらしています。
• 有利な規制承認と償還政策：規制当局の承認と償還制度は、侵襲的な画像技術の採用を促進し、革新的な機器開発への投資を促しています。

課題：

• 先端画像システムの高コスト：特に医療予算が限られている新興諸国では、先進的な画像診断システムの高コストが大きな課題となっています。この障壁が最先端画像技術の採用を抑制し、市場の成長を鈍化させています。
• データのプライバシーとセキュリティに関する懸念：クラウドベースの画像処理プラットフォームやAIを活用したアプリケーションの導入が進むにつれ、データのプライバシーやセキュリティに対する懸念が高まっています。医療提供者と患者の信頼関係を構築するには、規制の遵守と機密データの保護が不可欠です。
• 熟練労働力の不足：バイオイメージング分野における熟練した専門家の不足が、高度なイメージング技術の完全活用を妨げています。この課題は、高度な画像処理システムの操作に関する専門知識が乏しい開発途上地域で特に顕著です。

バイオイメージング市場が直面する促進要因・促進要因は、今後の市場動向を形成し、新技術の開発やイメージングサービスの拡大に影響を与えます。これらの課題に対処することで、利害関係者は市場の新たな機会を活用することができます。

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオイメージング市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のバイオイメージング市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のバイオイメージング市場：種類別
  • エラストグラフィー
  • 磁気共鳴画像 (MRI)
  • 医療用超音波検査/超音波
  • X線撮影
• 世界のバイオイメージング市場：技術別
  • 医学
  • 分子
• 世界のバイオイメージング市場：最終用途別
  • クリニック
  • 診断センター
  • 病院
  • 研究所

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のバイオイメージング市場：地域別
• 北米のバイオイメージング市場
• 欧州のバイオイメージング市場
• アジア太平洋のバイオイメージング市場
• その他地域のバイオイメージング市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のバイオイメージング市場の成長機会：種類別
  • 世界のバイオイメージング市場の成長機会：技術別
  • 世界のバイオイメージング市場の成長機会：最終用途別
  • 世界のバイオイメージング市場の成長機会：地域別
• 世界のバイオイメージング市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のバイオイメージング市場の生産能力拡大
  • 世界のバイオイメージング市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Bioclinica
• Bracco Imaging
• FONAR
• Bayer Healthcare Pharmaceuticals
• Covidin corp
• GE Healthcare
• GammaMedica

The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $19.7 billion by 2031 with a CAGR of 15.7% from 2025 to 2031. The major drivers for this market are the increasing demand for bioimaging instruments as an advancement in the imaging technologies, the rising prevalence of chronic diseases and the a aging world population, and the increasing number of diagnostic centers and radiopharmaceuticals.

• Lucintel forecasts that, within the type category, X-ray radiography is expected to witness the highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.
• Within the end use category, hospitals will remain the largest segment due to significantly growing developed infrastructure and advanced imaging facilities that enable hospitals to streamline their operations.
• In terms of regions, North America will remain the largest region during the forecast period due to the presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardiac diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Bio-Imaging Market

The bio-imaging industry is undergoing significant changes driven by new trends expected to transform the market. These trends are influenced by advancements in technology, the increasing demand for reliable and rapid diagnosis, and the integration of emerging modalities with artificial intelligence (AI) and machine learning. Several general trends are emerging as the market evolves. Some of the visible trends include the adoption of hybrid imaging techniques, developments in portable imaging solutions, and the utilization of cloud-based platforms. This section highlights five key emerging trends in the bio-imaging market, focusing on their implications for access to health services, diagnostic accuracy, and market growth.

• Integration of Imaging with AI: The integration of imaging with AI is a rapidly growing trend in the bio-imaging market, leading to improved accuracy and efficiency in imaging solutions. By utilizing deep learning technologies, AI can identify shapes and contours that may be missed by the human eye, especially in detecting diseases at early stages. AI also enables real-time analysis, reducing delays in diagnostics and facilitating faster decision-making. AI imaging tools are becoming more prominent in individualized treatment planning, where treatment approaches are based on patient-specific imaging data. This trend is accelerating the development of new imaging techniques and enhancing healthcare processes.
• Overlapping Imaging Technologies: Market intelligence reports indicate that the application of overlapping imaging technologies, such as PET/MRI and SPECT/CT, is becoming increasingly important. These systems combine the advantages of multiple imaging modalities to create comprehensive central images, improving diagnostic accuracy. For example, PET/MRI combines PET imaging of metabolic changes with MRI imaging of soft tissue structures, providing both functional and anatomical insights into pathological processes. Hybrid imaging is particularly beneficial for diagnosing cancer, heart disease, and brain conditions, where understanding both the problem and its treatment is critical. This development is contributing to the emergence of more flexible and advanced imaging systems.
• Portable and Point-of-Care Imaging Devices: The demand for portable and point-of-care imaging devices is rising, particularly in rural and remote areas where healthcare facilities require portable and easy-to-use solutions. Devices like portable ultrasound and handheld MRI are enabling doctors to conduct bedside diagnostics, providing faster and more convenient care for patients. These devices are especially important in emergencies, where rapid diagnostics can save lives. Additionally, advancements in miniaturization and wireless technology are enhancing the functionality of portable imaging systems, making them an integral part of modern healthcare.
• Platforms for Imaging Hosted in the Cloud: Cloud-based imaging platforms are transforming how imaging data is captured, stored, shared, and analyzed. These platforms enable integration with electronic health records and telehealth systems, providing users with access to imaging data regardless of their location. One of the key advantages of cloud platforms is collaborative diagnostics, where multiple healthcare providers can access and interpret the same data simultaneously. These platforms also address concerns related to data ownership, security, and access, making them a critical trend in the bio-imaging industry. As data privacy and security issues are resolved, this trend is expected to grow.
• Precision Oncology as a Course of Action in Theragnostic Research and Molecular Imaging: Molecular imaging and theragnostics are becoming increasingly important in oncology. These technologies enable imaging of both anatomical and pathological processes in the body, highlighting changes that can guide treatment decisions. The use of theragnostic agents, which combine diagnostic and therapeutic functions, is leading to more personalized treatments. The growing use of PET/CT and PET/MRI as molecular imaging techniques is facilitating the development of improved targeted radiopharmaceuticals for both diagnostic and therapeutic purposes.

The trends observed in the bio-imaging sector are transforming how healthcare services are delivered by increasing diagnostic and treatment efficiency, reducing costs, and enhancing patient satisfaction. These trends play a key role in driving the growth and advancement of the market, opening up new opportunities for market players.

Recent Developments in the Bio-Imaging Market

The bio-imaging market is undergoing significant changes that are reshaping its structure. Key developments include the integration of new imaging systems with AI, as well as strategic partnerships that are boosting market progress. The entry of miniaturized imaging devices, networked applications, and novel imaging modalities is enabling more accurate and timely diagnoses. These improvements are essential for the healthcare system, ensuring better patient care, streamlining processes, and supporting targeted treatments. This section focuses on five key areas of growth within the bio-imaging industry.

• AI-Based Imaging Tools: New AI-based imaging tools are making diagnoses more effective and expediting analysis in the bio-imaging industry. These tools use algorithms and data analysis to enhance the screening process for various diseases. AI-enhanced imaging devices are also helping develop patient-specific treatment plans, particularly for cancer and neurological diseases. This growing use of modern imaging technologies is creating a market for AI-powered bio-imaging solutions.
• Introduction of Cloud-Based Imaging Platforms: The introduction of cloud-based imaging platforms is a significant development in the bio-imaging industry. These platforms enable the secure storage, sharing, and analysis of imaging data, fostering collaboration among healthcare providers. Remote access to imaging data is particularly important for telemedicine and remote diagnostics. These platforms also address challenges related to data storage and management, offering solutions that meet the needs of users while accommodating increasing volumes of digital health tools.
• Introduction of Hybrid Imaging Systems: Hybrid imaging systems, such as PET/CT, PET/MRI, and SPECT/CT, combine multiple imaging modalities to provide a more comprehensive view of the body. The information from these systems is integrated to deliver both anatomical and functional insights, enhancing diagnostic accuracy. Hybrid imaging is particularly useful in oncology, cardiology, and neurology, where diagnostic precision is critical. The next generation of hybrid imaging systems is expected to bring further innovation and market expansion.
• Collaboration and Strategic Partnerships: Innovation in the bio-imaging market is being driven by collaboration and strategic partnerships between key players, including medical device companies, research institutions, and service providers. These partnerships are helping to accelerate the development and adoption of new imaging technologies.

Recent developments in bio-imaging, such as improvements in non-invasive probes, are enhancing the capabilities of imaging systems, improving patient treatment, and driving market growth. These developments are creating favorable conditions for stakeholders and offering new opportunities within the healthcare sector.

Strategic Growth Opportunities for Bio-Imaging Market

The bio-imaging market is identifying new strategic growth opportunities, driven by technological innovation, the demand for better diagnosis, and advancements in healthcare technology. These opportunities are crucial for stakeholders entering the growing market and pursuing innovations. This section outlines five growth opportunities by application and their roles in the bio-imaging market and the future of healthcare.

• Oncology Imaging: Oncology imaging is a major growth segment in the bio-imaging market due to the increasing incidence of cancer. Advanced imaging devices such as PET/CT, PET/MRI, and molecular imaging are used for accurate cancer diagnosis and treatment planning. The integration of AI in oncology imaging is improving the precision of tumor identification and enabling personalized treatment plans. This growth opportunity is attracting investment in the development of advanced imaging solutions, expanding the market from an oncology perspective.
• Neurology Imaging: Neurology imaging is another key growth segment due to the rising prevalence of neurological conditions such as Alzheimer's, Parkinson's disease, and multiple sclerosis. New imaging techniques, including functional MRI (fMRI), diffusion tensor imaging (DTI), and PET, are being used to diagnose and assess these diseases. Imaging methods are also evolving to meet the growing demand for rapid screening and detection of lesions and malignancies. This trend is creating growth opportunities for imaging solutions targeting neurology.
• Cardiology Imaging: The cardiology imaging market continues to grow due to the increasing incidence of cardiovascular diseases and the need for accurate diagnosis. The use of advanced imaging techniques such as 3D and 4D echocardiography, cardiac MRI, and CT angiography is providing safer ways to assess the heart without surgery. AI-based tools are also being integrated into cardiology imaging systems to enhance the diagnosis of heart diseases and improve operational efficiency. This market growth is spurring advances in cardiac imaging technologies, improving patient care.
• Orthopedic Imaging: The orthopedic imaging market is expanding due to the aging population and the rising prevalence of musculoskeletal disorders. Imaging techniques in orthopedics are not only helping with diagnosis but also guiding treatment planning and rehabilitation. Mobile imaging devices are particularly valuable in orthopedic practices, where timely diagnostics and therapeutic interventions are critical. This trend is increasing the demand for orthopedic imaging solutions and driving the development of advanced imaging techniques.
• Veterinary Imaging: Veterinary imaging is emerging as a key contributor to the growth of the bio-imaging market, driven by the demand for more sophisticated diagnostic tools in the animal health sector. Techniques such as ultrasound, MRI, and CT are increasingly being used for veterinary diagnostics, offering non-invasive solutions for animal care. Additionally, the development of AI-driven imaging solutions for veterinary care is enhancing diagnostic accuracy and workflow efficiency. This growth opportunity is unlocking new avenues for expansion in the bio-imaging market.

The bio-imaging market is experiencing significant growth due to advancements in technology and the increasing demand for accurate and effective diagnostic tools. These trends are creating new growth opportunities in various sectors, including oncology, neurology, cardiology, orthopedics, and veterinary care.

Bio-Imaging Market Driver and Challenges

The bio-imaging market is influenced by several drivers and challenges, including technological advancements, economic conditions, and regulatory policies. These factors play a crucial role in determining market growth, customer acceptance of imaging technologies, and the overall structure of the industry.

Drivers:

• Technological Improvements in Imaging Modalities: Continuous improvements in imaging technologies, such as the integration of AI, hybrid modalities, and wireless imaging systems, are driving growth in the bio-imaging market. These innovations are improving diagnostic accuracy and speed, contributing to market expansion.
• Rising Incidence of Chronic Diseases: The growing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological conditions, is increasing the demand for advanced imaging techniques. The need for swift and accurate diagnosis is driving the adoption of state-of-the-art imaging technologies.
• Increased Interest in Targeted Medicine: The growing trend of personalized medicine is driving demand for advanced imaging systems with high resolution, such as 3D and 4D imaging. These technologies are enabling more tailored therapeutic approaches, leading to better patient outcomes.
• Increase in Health Expenditure: Rising healthcare spending from both national governments and private investors is promoting the use of advanced imaging techniques. The improvement of healthcare facilities, especially in developing countries, is opening new growth opportunities for imaging solution providers.
• Favorable Regulatory Approvals and Reimbursement Policies: Regulatory approvals and reimbursement schemes are facilitating the adoption of invasive imaging technologies and encouraging investment in innovative equipment development.

Challenges:

• High Cost of Advanced Imaging Systems: The high cost of advanced imaging systems is a major challenge, especially in developing countries with limited medical budgets. This barrier reduces the adoption of cutting-edge imaging technologies, slowing market growth.
• Concerns About Data Privacy and Security: The increased adoption of cloud-based imaging platforms and AI-powered applications has raised concerns about data privacy and security. Ensuring compliance with regulations and protecting sensitive data is critical to building trust among healthcare providers and patients.
• Shortage of Skilled Workforce: A shortage of skilled professionals in the bio-imaging sector is preventing the full utilization of advanced imaging technologies. This challenge is particularly prevalent in developing regions, where expertise in operating sophisticated imaging systems is limited.

The drivers and challenges facing the bio-imaging market will shape its future trends, influencing the development of new technologies and the expansion of imaging services. Addressing these challenges will help stakeholders leverage emerging opportunities in the market.

List of Bio-Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-imaging companies profiled in this report include-

• Bioclinica
• Bracco Imaging
• Fonar
• Bayer Healthcare Pharmaceuticals
• Covidin
• GE Healthcare
• Gammamedica

Bio-Imaging by Segment

The study includes a forecast for the global bio-imaging market by type, technology, end use, and region.

Bio-Imaging Market by Type [Analysis by Value from 2019 to 2031]:

• Elastography
• Magnetic Resonance Imaging
• Medical Ultrasonography or Ultrasound
• X-Ray Radiography

Bio-Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

• Medical
• Molecular

Bio-Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

• Clinics
• Diagnostic Centers
• Hospitals
• Laboratories

Bio-Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bio-Imaging Market

The global bio-imaging market is undergoing significant advancements due to technological innovations, increased healthcare spending, and the rising demand for accurate diagnosis. Countries such as the United States, China, Germany, India, and Japan are at the forefront of these developments, each contributing distinct advancements that will impact the global market. Key trends include the introduction of AI, the exploration of new imaging modalities, and the formation of alliances among industry players. This section summarizes the developments in each of these countries, highlighting key trends and advancements in the bio-imaging sector.

• United States: The bio-imaging market in the United States is rapidly evolving, with a strong focus on integrating AI into imaging technologies. Partnerships between companies and research institutions are driving innovation, especially in the early diagnosis of diseases like cancer and neurological disorders. The U.S. FDA's approval of new imaging devices has improved diagnostic capabilities, while public interest in personalized medicine is pushing the demand for modern 3D and 4D imaging systems. Additionally, there is growing interest in cloud-based solutions for remote diagnostics.
• China: China's bio-imaging market is growing quickly, fueled by expanding healthcare infrastructure and a focus on local innovation. The country is adopting advanced imaging techniques, including molecular imaging and AI-based diagnostic tools. Chinese companies are forming alliances with international firms to enhance technological capabilities. Government policies supporting medical device innovation have led to the production of cost-effective yet sophisticated imaging systems. An aging population and the rising incidence of chronic diseases are further driving the demand for bio-imaging solutions.
• Germany: Germany continues to be a leader in the bio-imaging market, benefiting from its high-quality healthcare system and innovative developments. Recent advancements include the use of computer-aided detection (CAD) and image analysis (IA) systems to improve diagnostic performance. The adoption of hybrid imaging systems, such as PET/MRI and SPECT/CT, is also on the rise. Collaboration between hospitals, research institutions, and companies is fostering innovation, particularly in precision medicine for cancer and neurological diseases.
• India: India is experiencing steady growth in the bio-imaging market, with a focus on cost-effective and high-quality imaging solutions. The demand for imaging tools is increasing in rural areas, where remote diagnostics and AI-powered systems are playing a significant role. Government initiatives, such as the "Make in India" program, are promoting the development of homegrown bio-imaging technologies, making them more affordable and accessible. Public-private partnerships are also helping expand the availability of advanced imaging systems across the country.
• Japan: Japan's bio-imaging market is advancing rapidly, with a strong emphasis on new technologies such as 4D MRI and high-frequency ultrasound for better diagnostic imaging. The government is actively supporting the development of advanced imaging systems, and portable imaging devices combined with AI are becoming increasingly popular, especially for elderly care. Research on the longitudinal adoption of these technologies is also underway, with a focus on early diagnosis and patient comfort.

Features of the Global Bio-Imaging Market

Market Size Estimates: Bio-imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Bio-imaging market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Bio-imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the bio-imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bio-imaging market by type (elastography, magnetic resonance imaging, medical ultrasonography or ultrasound, and X-ray radiography), technology (medical and molecular), end use (clinics, diagnostic centers, hospitals, and laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bio-Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Bio-Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Bio-Imaging Market by Type
  • 3.3.1: Elastography
  • 3.3.2: Magnetic Resonance Imaging
  • 3.3.3: Medical Ultrasonography or Ultrasound
  • 3.3.4: X-ray Radiography
• 3.4: Global Bio-Imaging Market by Technology
  • 3.4.1: Medical
  • 3.4.2: Molecular
• 3.5: Global Bio-Imaging Market by End Use
  • 3.5.1: Clinics
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Hospitals
  • 3.5.4: Laboratories

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Bio-Imaging Market by Region
• 4.2: North American Bio-Imaging Market
  • 4.2.1: North American Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.2.2: North American Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.3: European Bio-Imaging Market
  • 4.3.1: European Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.3.2: European Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.4: APAC Bio-Imaging Market
  • 4.4.1: APAC Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.4.2: APAC Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.5: ROW Bio-Imaging Market
  • 4.5.1: ROW Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.5.2: ROW Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bio-Imaging Market by Type
  • 6.1.2: Growth Opportunities for the Global Bio-Imaging Market by Technology
  • 6.1.3: Growth Opportunities for the Global Bio-Imaging Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bio-Imaging Market by Region
• 6.2: Emerging Trends in the Global Bio-Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bio-Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bioclinica
• 7.2: Bracco Imaging
• 7.3: FONAR
• 7.4: Bayer Healthcare Pharmaceuticals
• 7.5: Covidin corp
• 7.6: GE Healthcare
• 7.7: GammaMedica